Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 93,611Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Strides Pharma Science

02 52care4

03 3ARCUTIS CANADA, INC.

04 1Abacus Medicine

05 1Abdi Ibrahim

06 2Accord healthcare

07 2Alkem Laboratories

08 3Arcutis Biotherapeutics

09 13AstraZeneca

10 2Aurobindo Pharma Limited

11 2Aurovitas Spain, Sau

12 2Ferrer Internacional

13 2Hetero Drugs

14 1KMS Health Center

15 1MS Pharma

16 2MSN Laboratories

17 1Medartuum

18 2Micro Labs Limited

19 3ORIFARM GROUP AS

20 1Orchid Pharma

21 1PHARMOBEDIENT

22 1Precise Group

23 1Prinston

24 2Senores Pharmaceuticals

25 1Takeda Pharmaceutical

26 4Torrent Pharmaceuticals Limited

27 2Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info : RX

Registration Country : USA

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2020-03-30

Application Number : 208247

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info : RX

Registration Country : USA

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-06-20

Application Number : 208247

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info :

Registration Country : India

Roflumilast

Brand Name : Roflumilast

Dosage Form : Tablet

Dosage Strength : 500MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 212490

Regulatory Info : RX

Registration Country : USA

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2011-02-28

Application Number : 22522

Regulatory Info : RX

Registration Country : USA

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2018-01-23

Application Number : 22522

Regulatory Info : RX

Registration Country : USA

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-11-23

Application Number : 208213

Regulatory Info : RX

Registration Country : USA

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208213

Regulatory Info : RX

Registration Country : USA

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2019-03-22

Application Number : 208180

Regulatory Info : RX

Registration Country : USA

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208180

Regulatory Info : RX

Registration Country : USA

blank

11

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2022-09-07

Application Number : 208256

Regulatory Info : RX

Registration Country : USA

blank

12

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-09-07

Application Number : 208256

Regulatory Info : RX

Registration Country : USA

blank

13

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-05-10

Application Number : 208299

Regulatory Info : RX

Registration Country : USA

blank

14

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-10-03

Application Number : 208236

Regulatory Info : DISCN

Registration Country : USA

blank

15

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-10-19

Application Number : 208236

Regulatory Info : DISCN

Registration Country : USA

blank

16

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-08-06

Application Number : 208272

Regulatory Info : DISCN

Registration Country : USA

blank

17

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2024-10-18

Application Number : 208272

Regulatory Info : RX

Registration Country : USA

blank

18

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-02-10

Application Number : 208303

Regulatory Info : RX

Registration Country : USA

blank

19

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208303

Regulatory Info : RX

Registration Country : USA

blank

20

PHARMOBEDIENT

Country
Aus. Peptide Conference
Not Confirmed
arrow

PHARMOBEDIENT

Country
arrow
Aus. Peptide Conference
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-07-13

Application Number : 208257

Regulatory Info : RX

Registration Country : USA

blank